Notes
J ournal of Natural Products, 2001, Vol. 64, No. 6 825
quantity of KCN (6.8 g, 0.105 mol) in H2O (30 mL) was added
and the mixture kept at room temperature for an additional
4 h. The CH2Cl2 layer was separated, partitioned consecutively
with H2O (2 × 100 mL), 2 M HCl (2 × 100 mL), 2 M NaOH (2
× 100 mL), and water (2 × 100 mL), and evaporated to
dryness. The resulting residue was crystallized from MeOH
as colorless needles (3.5 g, 42% yield) of 1-cyano-2-benzoyl-
6,7-dimethoxyisoquinoline (3): mp 182-183 °C; UV (MeOH)
λmax (log ꢀ) 226 (4.51), 250 (sh) (4.30), 312 (4.01) nm; IR (KBr)
νmax 2240, 1665, 1630, 1603, 1580, 1515, 1452, 1425, 1345,
1′′), 134.2 (C-4a), 130.1 (C-1′), 128.8 (C-2′′ and C-6′′), 128.2 (C-
4′′), 127.2 (C-3′′ and C-5′′), 126.8 (C-6′), 122.9 (C-8a), 121.4 (C-
4), 112.4 and 112.1 (C-2′ and C-5′), 104.9 and 104.2 (C-5 and
C-8), 70.9 (OCH2), 56.2 (OCH3), 56.2 (OCH3), 56.2 (OCH3);
EIMS m/z 429 [M+] (9), 338 (14), 188 (13), 91 (100).
P r ep a r a tion of 6,7-Dim eth oxy-3′-m eth oxy-4′-h yd r oxy-
oxoben zylisoqu in olin e (8). A solution of 6,7-dimethoxy-3′-
methoxy-4′-benzyloxyoxobenzylisoquinoline (6) (280 mg, 0.652
mmol) in HCl-HOAc (1:1) (20 mL) was refluxed for 2 h. The
solution was cooled, diluted with H2O (40 mL), alkalinized with
NH4OH to pH 8-9, and extracted with Et2O (3 × 50 mL). The
combined Et2O extracts were evaporated to a white residue,
which on crystallization from MeOH afforded 6,7-dimethoxy-
3′-methoxy-4′-hydroxyoxobenzylisoquinoline (8) as white cubic
crystals (140 mg, 64% yield): mp 179-180 °C; UV (MeOH)
λmax (log ꢀ) 240 (4.46), 315 (3.85) nm; UV (MeOH + 2 drops of
0.1 N NaOH) λmax (log ꢀ) 369 (3.88); IR (KBr) νmax 3453, 1650,
1581, 1506, 1488, 1432, 1410, 1286, 1231, 1160, 1138, 1052,
1027, 865, 732 cm-1; 1H NMR (DMSO-d6, 500 MHz) δ 3.78 (3H,
s, OCH3), 3.81 (3H, s, 3H, OCH3), 3.94 (3H, s, OCH3), 6.82 (1H,
d, J ) 8.5 Hz, H-5′), 7.15 (1H, dd, J ) 8.5 Hz, J ) 2.0 Hz,
H-6′), 7.25 (1H, s, H-8), 7.46 (1H, s, H-5), 7.55 (1H, d, J ) 2.0
Hz, H-2′), 7.82 (1H, d, J ) 5.5 Hz, H-4) 8.38 (1H, d, J ) 5.0
Hz, H-3); 13C NMR (CDCl3, 75 MHz) δ 193.5 (CdO), 154 (C-
1), 153.1 (C-7), 151.1 (C-6), 149.7 (C-3′), 148.2 (C-4′), 140.2 (C-
3), 133.8 (C-4a), 128.4 (C-1′), 127.3 (C-6′), 122.1 (C-8a), 121.4
(C-4), 115.3 (C-5′), 112.9 (C-2′), 105.9 (C-5), 103.7 (C-8), 56.2
(OCH3), 55.9 (OCH3), 55.8 (OCH3); HREIMS m/z 339.1091 [M+]
(calcd for C19H17O5N, 339.1106), 151.0393 (calcd for C8H7O3,
151.0395).
1285, 1231, 1146, 1107 cm-1 1H NMR (CDCl3, 400 MHz) δ
;
3.93 (3H, s, OCH3), 3.95 (3H, s, OCH3), 6.01 (1H, d, J ) 7.5
Hz, H-4), 6.52 (1H, s, H-1), 6.73 (1H, s, H-8), 6.86 (1H, s, H-5),
7.54 (5H, m, 5ArH), 8.11 (1H, d, J ) 7.15 Hz, H-3); 13C NMR
(CDCl3, 75 MHz) δ 168.8 (CdO), 150.3 and 149.2 (C-6 and C-7),
133.7 (C-1′), 132.3 and 132.0 (C-3 and C-4′), 130.2 (C-2′), 129.2
(C-3′), 128.7 and 128.4 (C-5′ and C-6′), 124.5 (C-4a), 123.5 (C-
8a), 116.6 (CtN), 110.0 (C-4), 109.6 and 108.7 (C-5 and C-8),
56.3 (OCH3), 56.1 (OCH3), 44.8 (C-1); EIMS m/z 320 [M]+ (27),
215 (7), 189 (25), 146 (5), 105 (100), 77 (43).
P r ep a r a tion of 3′-Meth oxy-4′-ben zyloxyp h en yl-1-(6,7-
d im eth oxyisoqu in olyl)ca r bin ol (4). To NaH (100 mg, 4.2
mmol) suspended in DMF (10 mL) at -10° was added 1-cyano-
2-benzoyl-6,7-dimethoxyisoquinoline (3) (1.0 g, 3.12 mmol) in
DMF (15 mL) over a period of 5 min under N2. After 5 min,
O-benzylvanillin (822 mg, 3.4 mmol) in DMF (10 mL) was
added over 10 min at -10 °C. The mixture was stirred for 2 h
at 0 °C and then allowed to stand at room temperature for an
additional 2 h. The mixture was treated with MeOH (50 mL)
and then evaporated. The residue was dissolved in C6H6 (40
mL), partitioned with H2O (2 × 30 mL), and evaporated. The
resulting residue, consisting primarily of the benzoate ester
of 4, was dissolved in EtOH (25 mL) and hydrolyzed with KOH
(0.2 g) in H2O (10 mL) under reflux for 3 h. The solution was
cooled and evaporated to dryness, and the resulting residue
was partitioned with Et2O (3 × 30 mL). The combined Et2O
extracts were evaporated to afford a white residue, which upon
crystallization from MeOH afforded 3′-methoxy-4′-benzyloxy-
phenyl-1-(6,7-dimethoxyisoquinolyl)carbinol (4) (500 mg, 37%
yield). The alcohol 4 had a mp of 142-143 °C; UV (MeOH)
P r ep a r a tion of 2-Meth yl-6,7-d im eth oxy-3′-m eth oxy-4′-
h yd r oxyoxoben zylisoqu in olin e Iod id e (1). To 6,7-dimeth-
oxy-3′-methoxy-4′-hydroxyoxobenzylisoquinoline (8) (40 mg,
0.118 mmol) in CH3CN (10 mL) was added CH3I (1 mL). The
solution was refluxed for 12 h, cooled, and evaporated to a
yellow residue (49 mg). Treatment of the residue with Me2CO
afforded 2-methyl-6,7-dimethoxy-3′-methoxy-4′-hydroxyoxo-
benzylisoquinoline iodide (1) as yellow crystals (40 mg, 72%
yield): mp 174-175 °C; UV (MeOH) λmax (log ꢀ) 220 (4.43),
256 (4.57), 302 (4.04), 327 (4.17) nm; UV (MeOH + 2 drops of
0.1 N NaOH) λmax (log ꢀ) 323 (4.05), 3.79 (4.23) nm; IR (KBr)
λmax (log ꢀ) 238 (4.68), 278 (3.88), 313 (3.73), 326 (3.72) nm; IR
(KBr) νmax 3500-3200, 1617, 1593, 1510, 1480, 1460, 1407,
1270, 1234, 1159, 1136, 1020 cm-1; 1H NMR (CDCl3, 400 MHz)
δ 3.72 (6H, s, 2-OCH3), 4.01 (3H, s, OCH3), 5.10 (2H, s, OCH2),
6.23 (1H, s, H-R), 6.67 (1H, d, J ) 8 Hz, H-8′), 6.77 (1H, d, J
) 8 Hz, H-6′), 6.92 (1H, s, H-8), 7.09 (1H, s, H-2′), 7.20 (1H, s,
H-5), 7.33 (5H, m, ArH), 7.63 (1H, d, J ) 5.8 Hz, H-4), 8.44
(1H, d, J ) 5.8 Hz, H-3); 13C NMR (CDCl3, 75 MHz) δ 156.5
(OCH3, C-6), 152.9 (OCH3, C-7), 150.0 (C-1 and C-4′), 147.8
(C-3′), 138.2 (C-3), 137.0 and 136.5 (C-1′ and C-1′′), 133.8 (C-
4a), 128.5 (C-2′′ and C-6′′), 127.8 (C-4′′), 127.2 (C-3′′ and C-5′′),
121.0 (C-6′), 120.2 and 120.0 (C-4 and C-8a), 113.8 (C-2′), 111.1
(C-5′), 105.3 (C-5), 103.4 (C-8), 72.5 (C-R), 70.9 (OCH2), 56.1
(OCH3), 56.0 (OCH3), 55.9 (OCH3); EIMS m/z 431 [M+] (100),
416 (10), 340 (27), 324 (8), 188 (25), 91 (19).
νmax 3420,1655, 1583, 1514, 1494, 1430, 1289, 1231, 1164, 1025,
994, 875, 755 cm-1; 1H NMR (DMSO-d6, 600 MHz,) δ 3.71 (3H,
s, OCH3, C-7), 3.85 (3H, s, OCH3, C-3′), 4.06 (3H, s, OCH3,
C-6), 4.13 (3H, s, NCH3), 6.85 (1H, d, J ) 6.6 Hz, H-6′), 6.88
(1H, s, H-8), 7.15 (1H, br s, H-5′), 7.61 (1H, br s, H-2′), 7.85
(1H, s, H-5), 8.42 (1H, d, J ) 6.6 Hz, H-4) 8.66 (1H, d, J ) 7.2
Hz, H-3), 10.94 (1H, s, OH); 13CNMR δ 190.0 (CdO), 162.3
(C-6), 158.1 (C-7), 155.9 (C-3′), 154.7 (C-1), 153.9 (C-4′), 141.2
(C-4a), 141.1 (C-3), 133.2 (C-5′), 130.3 (C-1′), 128.4 (C-4), 126.1
(C-8a), 120.6 (C-6′), 115.9 (C-2′), 111.1 (C-5), 108.7 (C-8), 61.6
(C-6) (OCH3), 60.8 (C-7) (OCH3), 60.4 (C-3′) (OCH3), 50.1
(NCH3); HREIMS m/z 353.1247 [M+ - HI] (calcd for C20H19O5N,
353.1263), 339.1100 (calcd for C19H17O5N, 339.1106).′′
P r ep a r a tion of 3′-Ben zyloxy-4′-m eth oxyp h en yl-1-(6,7-
d im eth oxyisoqu in olyl)ca r bin ol (5). To NaH (100 mg, 4.2
mmol) suspended in DMF (10 mL) at -10 °C was added
1-cyano-2-benzoyl-6,7-dimethoxyisoquinoline (3) (1.0 g, 3.12
mmol) in DMF (15 mL) over a period of 5 min under N2. After
5 min, O-benzylisovanillin (822 mg, 3.4 mmol) in DMF (10 mL)
was added over 10 min at -10 °C. The mixture was stirred
for 2 h at 0 °C and then allowed to stand at room temperature
for an additional 2 h. The mixture was treated with MeOH
(50 mL) and then evaporated to a residue that was dissolved
in C6H6 (40 mL), partitioned with H2O (2 × 30 mL), and
evaporated. The resulting residue, consisting primarily of the
benzoate ester of 5, was dissolved in EtOH (25 mL) and
hydrolyzed by KOH (0.2 g) in H2O (10 mL) under reflux for 3
h. The solution was cooled and evaporated to dryness, and the
resulting residue was treated with Et2O (3 × 30 mL). The
combined Et2O extracts were evaporated to a white residue,
which upon crystallization from MeOH afforded 3′-benzyloxy-
4′-methoxyphenyl-1-(6,7-dimethoxyisoquinolyl)carbinol (5) (430
mg, 32% yield): mp of 140-141 °C; UV (MeOH) λmax 239 (4.68),
278 (3.88), 313 (3.72), 326 (3.57) nm; IR (KBr) νmax 3437, 1622,
P r epar ation of 6,7-Dim eth oxy-3′-m eth oxy-4′-ben zyloxy-
oxoben zylisoqu in olin e (6). To 3′-methoxy-4′-benzyloxyphe-
nyl-1-(6,7-dimethoxyisoquinolyl)carbinol (4) (400 mg, 0.92
mmol) in HOAc (5 mL) was added a solution of Na2CrO4 (620
mg, 3.78 mmol) in HOAc (5 mL). The mixture was heated for
3 min on a steam bath, diluted with H2O (50 mL), alkalinized
with NH4OH to pH 8-9, and partitioned with Et2O (3 × 50
mL). The Et2O extracts were combined and evaporated, and
the resulting residue was treated with MeOH to afford 6,7-
dimethoxy-3′-methoxy-4′-benzyloxyoxobenzylisoquinoline (6)
as yellow crystals (303 mg, 75% yield): mp 170 °C; UV (MeOH)
λ
max (log ꢀ) 237 (4.49), 280 (3.99), 326 (3.97) nm; IR (KBr) νmax
1655, 1591, 1505, 1477, 1415, 1267, 1235, 1157, 1137, 1032,
861, 753 cm-1 1H NMR (CDCl3, 400 MHz) δ 3.95 (3H, s,
;
OCH3), 3.98 (3H, s, OCH3), 4.08 (3H, s, OCH3), 5.24 (2H, s,
OCH2), 6.87 (1H, d, J ) 8.4 Hz, H-5′), 7.17 (1H, s, H-8), 7.35
(6H, m, H-6′ and 5ArH), 7.48 (1H, s, H-5), 7.73 (2H, d, J ) 1.5
Hz, H-4 and H-2′), 8.45 (1H, d, J ) 5.2 Hz, H-3); 13C NMR
(CDCl3, 75 MHz) δ 193.8 (CdO), 153.6 and 153.4 (C-6 and C-7),
153.1 (C-1), 151.2 (C-4′), 149.6 (C-3′), 139.8 (C-3), 136.3 (C-